Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Sani

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Journal of Medicinal Chemistry|June 23, 1995
Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activityM Alam, V Zhestkov, B P Sani, et al.
Anti-Cancer Drug Design|January 1, 1997
Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancerY F Shealy, J L Frye, J M Riordan, et al.
Journal of Medicinal Chemistry|December 23, 1994
A conformationally defined 6-s-trans-retinoic acid isomer: synthesis, chemopreventive activity, and toxicityM F Vaezi, M Alam, B P Sani, et al.
Journal of Medicinal Chemistry|September 13, 1996
Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activityD D Muccio, W J Brouillette, M Alam, et al.
Journal of Medicinal Chemistry|July 1, 1989
Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoidsM I Dawson, P D Hobbs, K A Derdzinski, et al.
Anti-Cancer Drug Design|May 22, 1998
Retinyl substituted-benzyl ethers. Inhibition of mammary carcinogenesis by retinyl 3,4,5-trimethoxybenzyl ether (RTMBE)Y F Shealy, J L Frye, D L Hill, et al.
Journal of Medicinal Chemistry|May 30, 1998
Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemiasD D Muccio, W J Brouillette, T R Breitman, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Journal of Medicinal Chemistry|June 23, 1995
Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activityM Alam, V Zhestkov, B P Sani, et al.
Anti-Cancer Drug Design|January 1, 1997
Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancerY F Shealy, J L Frye, J M Riordan, et al.
Journal of Medicinal Chemistry|December 23, 1994
A conformationally defined 6-s-trans-retinoic acid isomer: synthesis, chemopreventive activity, and toxicityM F Vaezi, M Alam, B P Sani, et al.
Journal of Medicinal Chemistry|September 13, 1996
Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activityD D Muccio, W J Brouillette, M Alam, et al.
Journal of Medicinal Chemistry|July 1, 1989
Effect of structural modifications in the C7-C11 region of the retinoid skeleton on biological activity in a series of aromatic retinoidsM I Dawson, P D Hobbs, K A Derdzinski, et al.
Anti-Cancer Drug Design|May 22, 1998
Retinyl substituted-benzyl ethers. Inhibition of mammary carcinogenesis by retinyl 3,4,5-trimethoxybenzyl ether (RTMBE)Y F Shealy, J L Frye, D L Hill, et al.
Journal of Medicinal Chemistry|May 30, 1998
Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemiasD D Muccio, W J Brouillette, T R Breitman, et al.
Pageof 7